US moves to fast-track psychedelic drug reviews
Follow spoken words in real time.
The US health authority has given three companies a special chance to develop new psychedelic drugs for mental illness more quickly. This action comes soon after the President signed a new order to speed up access to these kinds of therapies. The three companies were given a national priority, so their drug applications will receive a faster review.
Interest in psychedelic-based medicines is increasing. These drugs are being tested for problems like depression and post-traumatic stress disorder. Some people hope that faster testing will help patients who have not improved with usual treatments.
There are still concerns about safety, correct dosage, and long-term effects. Many psychedelic drugs are still strongly restricted. The faster review does not mean that the drugs are approved automatically, but it shows that the government wants to pay more attention to these possible new treatments.
Today's News
Vocabulary
6 wordsofficial group or organisation in control
something considered more important than others
careful examination of something by experts
limited, not freely available or allowed
officially accepted or allowed by authority
care or notice given to something important
Ready to learn these 6 words?
About 8 minutes · 5 activities
Reading Quizzes
9 questionsWhat did the US health authority do for three companies?
Choose an answer to continue
Great for IELTS, TOEFL, SAT, IB, A-Level and everyday English speaking practice.





